Pharmacotherapy

Papers
(The TQCC of Pharmacotherapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19184
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019150
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19133
COVID‐19 Clinical Diagnostics and Testing Technology98
Therapeutic Potential for Tetracyclines in the Treatment of COVID‐1985
Considerations for Statin Therapy in Patients with COVID‐1978
Managing COVID‐19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid‐sparing Immunosuppression67
A guide to therapeutic drug monitoring of β‐lactam antibiotics58
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management54
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐1953
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections52
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism51
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin‐Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of H49
Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient48
Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention43
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series41
Evaluation of Eravacycline: A Novel Fluorocycline35
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I31
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective31
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens28
Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review27
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide25
Model‐Based Analysis of Cannabidiol Dose‐Exposure Relationship and Bioavailability25
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD24
Optimizing anticoagulation for patients receiving Impella support22
Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity22
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections22
An Overview of the Treatment of Less Common Non–Lactose‐Fermenting Gram‐Negative Bacteria22
CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis21
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?21
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn20
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review20
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease19
Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current Evidence18
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review18
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐1918
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies18
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial17
Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults17
Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review17
Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease17
CBD and THC: Do They Complement Each Other Like Yin and Yang?16
Antibiotics in the Biliary Tract: A Review of the Pharmacokinetics and Clinical Outcomes of Antibiotics Penetrating the Bile and Gallbladder Wall16
Scoping review of augmented renal clearance in critically ill pediatric patients16
Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic review15
Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐Analysis15
Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program13
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study13
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug‐drug interactions according to CYP2D6 phenotypes13
Comparison of Hydromorphone versus Fentanyl‐based Sedation in Extracorporeal Membrane Oxygenation: A Propensity‐Matched Analysis13
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation13
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability13
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic13
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design12
Gut microbiome health and dysbiosis: A clinical primer12
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta‐analysis12
Cisplatin‐induced nephrotoxicity in an outpatient setting12
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients11
Evolving Therapeutic Options for Chronic Graft‐versus‐Host Disease11
Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High‐Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma11
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline11
Combining Antidepressants with β‐Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction11
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review11
The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis11
Use of psychiatric medication by college students: A decade of data11
Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial11
Advances in CAR T Therapy for Hematologic Malignancies11
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients11
Hydroxychloroquine in Hospitalized Patients with COVID‐19: Real‐World Experience Assessing Mortality10
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve10
Anticholinergic medication burden and cognitive function in participants of the ASPREE study10
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling10
Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics10
Tebipenem pivoxil hydrobromide—No PICC, no problem!10
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease10
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 10
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials10
Reduced alternative insulin dosing in hyperkalemia: A meta‐analysis of effects on hypoglycemia and potassium reduction10
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease10
Prophylactic norepinephrine infusion for postspinal anesthesia hypotension in patients undergoing cesarean section: A randomized, controlled, dose‐finding trial10
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies10
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock9
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care9
Using l‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis9
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients9
Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program9
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study9
Myocardial infarction associated with erenumab: A case report8
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study8
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–20168
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients8
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity8
Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis8
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation8
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management8
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se8
Glucagon: Its evolving role in the management of hypoglycemia8
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review7
Immunosuppression considerations in simultaneous organ transplant7
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents7
Effects of β2‐Adrenergic Agonists on Risk of Parkinson's Disease in COPD: A Population‐Based Study7
Treprostinil Attains Clinically Therapeutic Concentrations in Neonates with Pulmonary Hypertension on Extracorporeal Membrane Oxygenation Support7
Intensive Care Unit Delirium in Surgical Patients Is Associated with Upregulation in Tryptophan Metabolism7
National Trends in Oral Antibiotic Prescribing in United States Physician Offices from 2009 to 20167
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy7
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms7
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision7
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection7
The role of inflammation in the pathogenesis and treatment of arrhythmias7
Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Target7
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series7
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m27
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction7
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function6
Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies6
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the6
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections6
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma6
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy6
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke6
Pharmacotherapy for durable left ventricular assist devices6
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report6
Melatonin Use in Hospitalized Children for Non‐Anesthetic Indications: A Systematic Review6
Factors influencing antibiotic duration in culture‐negative neonatal early‐onset sepsis6
A Systematic Review and Meta‐Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure6
Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System6
The Impact of Proximal Roux‐en‐Y Gastric Bypass Surgery on Acetaminophen Absorption and Metabolism6
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics6
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage6
COVID‐19: The Uninvited Guest in the Intensive Care Unit — Implications for Pharmacotherapy6
Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients6
First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients6
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration6
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study6
Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low‐Efficiency Dialysis6
Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example6
Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation6
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review6
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial6
0.033519983291626